Condition: Dementia · Alzheimer Disease · Sponsor: University Hospital, Geneva
The objective of the study is to investigate the clinical validity of tau-PET with \[18F\]RO948 vs. amyloid-PET in patients with Mild Cognitive Impairment (MCI) or mild dementia
This description comes directly from the study's public registry record.
Valentina Garibotto, MD · +41223727252 · valentina.garibotto@hug.ch
Always discuss trial participation with your own doctor first.
| Geneva University Hospital | Geneva, Canton of Geneva, Switzerland | Recruiting |
| Centre Medical Universitaire Vaudois | Lausanne, Canton of Vaud, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06618872